Comparative evaluation of Point of Care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients Carles Iniesta-Navalón; Manuel Ríos-Saorín; Lorena Rentero-Redondo; Rebeca Añez-Castaño; Elena Urbieta-Sanz;

Optimizing outcomes with maintenance IV UST in highly bio-exposed patients with IBD. Efficacy and Adjusted Regimen in Real World A. Mínguez; E. Coello; A. Garrido; P. Ripoll; M. Gomez; M. Aguas; M. Iborra; E. Cerrillo; L. Tortosa; V. Bayarri; N. Bueno; MJ Fernández; R. Marqués; P. Nos; G. Bastida;

Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study Lidia Serrano Díaz; Carles Iniesta Navalón; Rosa Gómez Espín; Isabel Nicolás De Prado; Enrique Bernal Morell; Lorena Rentero Redondo;